Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $6.98 | Prev. Close $6.98 | Circuit Range N/A |
Day Range $6.79 - $7.09 | Year Range $0.56 - $7.99 | Volume 1,11,199 |
Average Traded $6.95 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $6.98 | $6.93 | +0.00% |
30-Jun-26 | $6.98 | $6.93 | -1.00% |
29-Jun-26 | $6.60 | $7.00 | +5.26% |
26-Jun-26 | $6.44 | $6.65 | +3.42% |
25-Jun-26 | $6.49 | $6.43 | -1.15% |
24-Jun-26 | $6.76 | $6.50 | -3.70% |
23-Jun-26 | $6.67 | $6.75 | -1.82% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?